Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Expands By 102.5%

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 4,744,953 shares, an increase of 102.5% from the June 15th total of 2,343,632 shares. Based on an average daily volume of 15,984,868 shares, the days-to-cover ratio is currently 0.3 days. Approximately 10.3% of the shares of the company are short sold.

Insiders Place Their Bets

In other news, CEO Grigorios Siokas acquired 701,447 shares of the company’s stock in a transaction on Wednesday, June 10th. The shares were bought at an average cost of $0.23 per share, with a total value of $161,332.81. Following the purchase, the chief executive officer owned 13,263,361 shares of the company’s stock, valued at $3,050,573.03. This represents a 5.58% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Georgios Terzis bought 168,135 shares of Cosmos Health stock in a transaction dated Tuesday, June 16th. The stock was purchased at an average price of $0.25 per share, with a total value of $42,033.75. Following the purchase, the chief financial officer directly owned 2,235,398 shares in the company, valued at approximately $558,849.50. This trade represents a 8.13% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders purchased 1,088,029 shares of company stock worth $249,240. 26.15% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cosmos Health

A number of large investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC lifted its holdings in shares of Cosmos Health by 16.7% in the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock valued at $124,000 after purchasing an additional 55,925 shares in the last quarter. XTX Topco Ltd increased its position in Cosmos Health by 52.1% during the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after purchasing an additional 34,117 shares in the last quarter. Finally, Citadel Advisors LLC grew its holdings in shares of Cosmos Health by 133.1% during the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after buying an additional 128,776 shares in the last quarter. 12.61% of the stock is owned by institutional investors and hedge funds.

Cosmos Health Price Performance

Cosmos Health stock traded down $0.03 during mid-day trading on Friday, reaching $0.25. The company had a trading volume of 1,971,179 shares, compared to its average volume of 4,606,501. The stock’s 50-day simple moving average is $0.25 and its 200-day simple moving average is $0.35. Cosmos Health has a 1 year low of $0.16 and a 1 year high of $1.32. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.08 and a quick ratio of 0.92. The company has a market capitalization of $15.46 million, a P/E ratio of -0.39 and a beta of 4.83.

Cosmos Health (NASDAQ:COSM) last released its quarterly earnings results on Wednesday, May 20th. The company reported ($0.06) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.06). The business had revenue of $18.40 million for the quarter, compared to analysts’ expectations of $17.93 million. Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%. On average, equities analysts predict that Cosmos Health will post -0.06 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Cosmos Health in a research note on Monday, June 15th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.